Endocannabinoid System Trauma Treatment and PTSD Research
Endocannabinoid system clinical research PTSD treatment reveals cannabis use does not impair trauma-focused therapy outcomes. Trauma-focused therapy remains effective for PTSD with substance use disorders. This research supports access to trauma-focused…
Endocannabinoid System and Pregnancy: Clinical Evidence
Prenatal alcohol exposure polysubstance use frequently occurs alongside other substances, increasing risks to fetal development. Understanding these patterns aids clinicians in screening and intervention. This study provides real-world data to guide…
Endocannabinoid System Clinical Research: Cannabis DKJ127 Trial
The Cannabis DK127 clinical trial demonstrated significant pain reduction in chronic low back pain patients using the full-spectrum cannabis extract VER-01. This phase 3 study showed sustained benefits over 12 weeks compared to placebo. The trial…
Evaluating Safety in Cannabinoid Clinical Trials for Mental Health
Cannabinoid clinical trials mental health safety data reveal limited evidence supporting cannabinoids as primary treatments for mental disorders. Current trials show inconclusive efficacy and safety profiles. Patients should prioritize evidence-based…
Impact of Maternal Cannabis Exposure on Child Neurodevelopment
Maternal cannabis exposure and risk of ASD ADHD in offspring is a critical area of research. Studies show associations between peripregnancy cannabis use and behavioral outcomes in children. These findings highlight the importance of understanding…
Clinical Trial of CBD Oil Effects on Autism and Anxiety
The CBD oil autism anxiety trial demonstrated measurable improvements in social relating and anxiety symptoms in autistic children. This randomized controlled study used a weight-based dosing approach over 12 weeks. Findings suggest potential benefits of…
Understanding Cannabis-Induced Psychosis and Psychiatric Progression
Cannabis-induced psychosis schizophrenia bipolar progression is a critical clinical concern. Patients with cannabis-induced psychosis have measurable risk for schizophrenia spectrum or bipolar disorder. Long-term monitoring is essential to identify those…
Clinical Trials of CBD for Anxiety and Tourette
CBD anxiety clinical trials demonstrate promising efficacy for generalized and social anxiety disorders with good safety. THC formulations show mixed results and possible anxiety worsening at high doses. Current evidence supports CBD as an adjunctive…
Digital Smoking Cessation Programs in HIV Care
Digital smoking cessation programs HIV provide tailored support for people living with HIV. These programs enable remote access to evidence-based cessation tools. Digital therapeutics show promising effectiveness in this underserved population.
Cannabidiol Supplements and WADA-Prohibited Cannabinoids
Broad-spectrum CBD supplements doping risk athletes face is a growing concern due to detectable prohibited cannabinoids in urine and blood. Exercise may amplify cannabinoid absorption or excretion, increasing detection risk. Athletes should verify…
